白蛋白–胆红素列线图对肝癌术后患者无瘤生存率的影响  

Effect of Albumin-Bilirubin Nomogram on Tumor Free Survival in Patients with Liver Cancer after Operation

作　　者：虞旭东[1] 童秀萍[1] 龚俊平[1] 洪小飞[1] 雷鑫明 

机构地区：[1]义乌市中心医院,浙江 义乌

出　　处：《世界肿瘤研究》2022年第4期205-210,共6页World Journal of Cancer Research

摘　　要：目的:探讨白蛋白–胆红素列线图对肝癌术后患者无瘤生存率的影响。方法:搜集本院肝癌手术患者,通过Kaplan-Meier方法和对数秩检验方法比较无瘤生存率(DFS),建立白蛋白–胆红素列线图判断其预测价值。结果:白蛋白–胆红素评分可作为肝癌患者术后无瘤生存率的独立危险因素且列线图C-指数为0.645。结论:白蛋白–胆红素列线图对于肝癌无瘤生存率具有预测作用,可在临床工作中提供指导。Objective: To investigate the effect of Albumin-Bilirubin nomogram on the tumor free survival rate of patients with liver cancer after operation. Methods: Collect patients with liver cancer in our hospital, compare tumor free survival (DFS) by Kaplan Meier method and log rank test, and establish Albumin-Bilirubin nomogram to judge its predictive value. Results: Albumin-Bilirubin score can be used as an independent risk factor for tumor free survival in patients with liver cancer, and the C-index of nomogram is 0.645. Conclusion: Albumin-Bilirubin nomogram can predict the tumor free survival rate of liver cancer and provide guidance in clinical work.

关 键 词：白蛋白–胆红素 列线图 肝癌 影响 

分 类 号：R735.7[医药卫生—肿瘤]